Head-to-Head

Amneal Pharmaceuticals, Inc. Class A Common Stock vs. Johnson & Johnson

AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock

$19.45 -2.51%

VS JNJ

Johnson & Johnson

$283.11 +0.96%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

AMRXJNJ
Market Cap $6.95 billion $675.03 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

AMRXJNJ
Dividend Yield — 1.89%

AMRX and JNJ split the dividend factors evenly.

Risk & Sentiment

AMRXJNJ
Short Interest 2.39% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: AMRX overview, AMRX financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.